Income and outcome in myelodysplastic syndrome: the prognostic impact of SES in a single-payer system.
Leuk Res
; 37(11): 1495-501, 2013 Nov.
Article
in En
| MEDLINE
| ID: mdl-24095584
ABSTRACT
We examined the prognostic impact of SES, estimated by census median household income, in 312 adult MDS patients. Age, progression to AML, use of recombinant erythropoietin, WHO diagnosis and IPSS risk category were independent predictors of survival but there was no association between SES and survival. Unexpectedly, progression to AML was more prevalent in the highest income quartile (HR 3.96 for highest vs. lowest; p=0.0032). The previously demonstrated association of low SES with poor outcome MDS in the United States may have been driven primarily by reduced access to care rather than other SES-linked factors such as co-morbidity.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Myelodysplastic Syndromes
/
Antineoplastic Combined Chemotherapy Protocols
/
Single-Payer System
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
Leuk Res
Year:
2013
Type:
Article
Affiliation country:
Canada